Use of interleukin-22 in the treatment of fatty liver disease
US10786551B2 · kind B2 · utility
2Cited by
42References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 1, 2017 |
| Grant date | Sep 29, 2020 |
| Priority date | — |
| Expiry date | Sep 1, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to use of interleukin-22 (IL-22) for treating fatty liver disease by decreasing the levels of transaminases. The use of IL-22 in decreasing the levels of transaminases is also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.